Nandini Kishore

2.4k total citations · 1 hit paper
20 papers, 1.9k citations indexed

About

Nandini Kishore is a scholar working on Immunology, Cancer Research and Oncology. According to data from OpenAlex, Nandini Kishore has authored 20 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 13 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Nandini Kishore's work include NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (11 papers) and Cytokine Signaling Pathways and Interactions (11 papers). Nandini Kishore is often cited by papers focused on NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (11 papers) and Cytokine Signaling Pathways and Interactions (11 papers). Nandini Kishore collaborates with scholars based in United States, United Kingdom and Canada. Nandini Kishore's co-authors include Debra M. Meyer, Martin E. Dowty, Michael I. Jesson, John J. O’Shea, Sumathy Mathialagan, Sarbani Ghosh, Catherine S. Tripp, Arian Laurence, Samuel H. Zwillich and Gary Chan and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Nandini Kishore

20 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

2011 514 citations Kamran Ghoreschi, Michael I. Jesson et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Nandini Kishore

Since Specialization

Citations

This map shows the geographic impact of Nandini Kishore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nandini Kishore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nandini Kishore more than expected).

Fields of papers citing papers by Nandini Kishore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nandini Kishore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nandini Kishore. The network helps show where Nandini Kishore may publish in the future.

Co-authorship network of co-authors of Nandini Kishore

This figure shows the co-authorship network connecting the top 25 collaborators of Nandini Kishore. A scholar is included among the top collaborators of Nandini Kishore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nandini Kishore. Nandini Kishore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical to Clinical Translation of Tofacitinib, a Janus Kinase Inhibitor, in Rheumatoid Arthritis 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Martin E. Dowty, Michael I. Jesson, Sarbani Ghosh, (unknown), Debra M. Meyer, Sriram Krishnaswami, Nandini Kishore	88
2	AB0160 Effects of TOFACITINIB (CP-690,550) on lipid biomarkers in rat adjuvant-induced arthritis (AIA) model and in patients with active rheumatoid arthritis 2012 ·Annals of the Rheumatic Diseases ·Iain B. McInnes, Irina V Kaplan, M. Boy, Richard J. Riese, (unknown), James D. Clark, Nandini Kishore, M. Julia Brosnan, Samuel H. Zwillich, John Bradley	1
3	Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550) breakdown → 2011 ·The Journal of Immunology ·Kamran Ghoreschi, Michael I. Jesson, Li Xiong, (unknown), Sarbani Ghosh, (unknown), (unknown), Masao Tanaka, Scott Steward-Tharp, Massimo Gadina, Craig J. Thomas, John C. Minnerly, Chad Storer, Timothy P. LaBranche, Zaher A. Radi, Martin E. Dowty, Richard D. Head, Debra M. Meyer, Nandini Kishore, John J. O’Shea	514
4	Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis 2010 ·Journal of Inflammation ·Debra M. Meyer, Michael I. Jesson, Xiong Li, Mollisa M. Elrick, (unknown), (unknown), Cindy Gross, Martin E. Dowty, Shashi K. Ramaiah, Jeffrey L. Hirsch, Matthew J. Saabye, Jennifer Barks, Nandini Kishore, Dale L. Morris	384
5	Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure–activity relationship 2010 ·Bioorganic & Medicinal Chemistry ·Jin Xie, Gennadiy Poda, Yiding Hu, (unknown), Richard F. Heier, (unknown), Matthew T. Reding, Patrick J. Lennon, Ravi G. Kurumbail, Shaun R. Selness, Xiong Li, Nandini Kishore, Cynthia D. Sommers, (unknown), Sheri L. Bonar, (unknown), Sumathy Mathialagan, (unknown), H. T. Huang	14
6	Anti-inflammatory effect of a selective IκB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke 2010 ·Pulmonary Pharmacology & Therapeutics ·R. Saravanan, Jae‐Woong Hwang, Hongwei Yao, Nandini Kishore, Irfan Rahman	39
7	Expression, purification and functional characterization of IκB kinase-2 (IKK-2) mutants 2010 ·Protein Expression and Purification ·Sumathy Mathialagan, Gennadiy Poda, Ravi G. Kurumbail, Shaun R. Selness, Troii Hall, Beverly A. Reitz, Robin A. Weinberg, Nandini Kishore, Gabriel Mbalaviele	4
8	Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-κB Essential Modulator Binding Domain Peptides 2010 ·Journal of Biological Chemistry ·(unknown), Julia A. Guzova, Sumathy Mathialagan, (unknown), Medora M. Hardy, (unknown), Sheri L. Bonar, Robin A. Weinberg, Shaun R. Selness, Scott S. Woodard, Jill Chrencik, William F. Hood, John F. Schindler, Nandini Kishore, Gabriel Mbalaviele	38
9	A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Gabriel Mbalaviele, Cynthia D. Sommers, Sheri L. Bonar, Sumathy Mathialagan, John F. Schindler, Julia A. Guzova, Alexander F. Shaffer, (unknown), (unknown), Catherine S. Tripp, Po‐Chang Chiang, David C. Thompson, Yiding Hu, Nandini Kishore	56
10	Combined use of pharmacokinetic modeling and a steady-state delivery approach allows early assessment of IκB kinase-2 (IKK-2) target safety and efficacy 2009 ·Journal of Pharmaceutical Sciences ·Po‐Chang Chiang, Nandini Kishore, David C. Thompson	5
11	Protein Kinase Cζ Mediates Cigarette Smoke/Aldehyde- and Lipopolysaccharide-induced Lung Inflammation and Histone Modifications 2009 ·Journal of Biological Chemistry ·Hongwei Yao, Jae‐Woong Hwang, Jorge Moscat, María T. Díaz‐Meco, Michael Leitges, Nandini Kishore, (unknown), Irfan Rahman	50
12	Novel Tight-Binding Inhibitory Factor-κB Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Cynthia D. Sommers, Janice Thompson, Julia A. Guzova, Sheri L. Bonar, Randall K. Rader, Sumathy Mathialagan, (unknown), (unknown), Larry E. Kahn, (unknown), (unknown), H. T. Huang, Po‐Chang Chiang, John F. Schindler, Yiding Hu, Debra M. Meyer, Nandini Kishore	28
13	Therapeutic targeting of Janus kinases 2008 ·Immunological Reviews ·Marko Pesu, Arian Laurence, Nandini Kishore, Samuel H. Zwillich, Gary Chan, John J. O’Shea	173
14	Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarboxamides 2005 ·Bioorganic & Medicinal Chemistry Letters ·D. Bonafoux, Sheri L. Bonar, (unknown), Michael Clare, (unknown), Julia A. Guzova, Nandini Kishore, Patrick J. Lennon, Adam H. Libby, Sumathy Mathialagan, (unknown), (unknown), (unknown), Michael B. Tollefson, Catherine S. Tripp, Richard M. Weier, (unknown), Min Yao	24
15	A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts 2003 ·Journal of Biological Chemistry ·Nandini Kishore, (unknown), Sumathy Mathialagan, Julia A. Guzova, Min Yao, Scott D. Hauser, (unknown), Sheri L. Bonar, (unknown), Lee D. Albee, Richard M. Weier, Matthew J. Graneto, (unknown), Thao Perry, Catherine S. Tripp	247
16	Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease 2003 ·Bioorganic & Medicinal Chemistry ·Srinivasan Nagarajan, (unknown), Daniel P. Getman, (unknown), James A. Sikorski, (unknown), Joseph J. McDonald, Kathryn Houseman, (unknown), Nandini Kishore, Pramod P. Mehta, (unknown), (unknown)	80
17	Kinetic Mechanisms of IκB-related Kinases (IKK) Inducible IKK and TBK-1 Differ from IKK-1/IKK-2 Heterodimer 2002 ·Journal of Biological Chemistry ·Q K Huynh, Nandini Kishore, Sumathy Mathialagan, (unknown), Catherine S. Tripp	22
18	IKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2 2002 ·Journal of Biological Chemistry ·Nandini Kishore, Q K Huynh, Sumathy Mathialagan, Troii Hall, (unknown), David Creely, Gary Lange, (unknown), (unknown), (unknown), (unknown), Rodney G. Combs, K K Kretzmer, Catherine S. Tripp	115
19	Discovery of a novel series of selective MMP inhibitors: Identification of the γ-sulfone-thiols 1999 ·Bioorganic & Medicinal Chemistry Letters ·John N. Freskos, (unknown), Gary DeCrescenzo, R. Heintz, Daniel P. Getman, Susan C. Howard, Nandini Kishore, Joseph J. McDonald, Grace E. Munie, Shaukat H. Rangwala, Craig Swearingen, Charles F. Voliva, Dean J. Welsch	21
20	(Hydroxyethyl) sulfonamide HIV-1 Protease inhibitors: Identification of the 2-methylbenzoyl moiety at P-2 1996 ·Bioorganic & Medicinal Chemistry Letters ·John N. Freskos, (unknown), Daniel P. Getman, R. Heintz, (unknown), (unknown), Martin L. Bryant, (unknown), (unknown), Nandini Kishore, (unknown), Pramod P. Mehta	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact